Company intelligence / Profile preview

BVI Medical

Sarasota, Florida, United Statesbvimedical.com ↗

Ownership: Private
Development stage: Commercial

Overview

BVI Medical has a broad commercial portfolio of surgical devices for ophthalmology. Its latest innovation—Leos™ Laser Endoscopy Ophthalmic System—received FDA 510(k) clearance in April 2025 for minimally invasive glaucoma surgery. Leos™ demonstrated safety and efficacy in a randomized controlled clinical trial and will be commercially launched in the US in 2025

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Not specified; distributes through global network

Beyond the preview

Go deeper on BVI Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BVI Medical.

Explore the full profile